DUBAI (Reuters) – The United Arab Emirates health ministry said on Wednesday an interim analysis of in-country Phase III clinical trials of Sinopharm’s COVID-19 vaccine has 86% efficacy against the infection.
It also said it had registered the vaccine, for which it approved emergency use in September for certain groups.
(Writing by Alexander Cornwell; Editing by Sam Holmes)
